Bartscancer.london

Thomas Powles named in TIME's list of the 100 most influential …

WEBTIME100 Health recognises the impact, innovation, and achievement of the world’s most influential individuals in health. Professor Powles, who is also Director of …

Actived: 8 days ago

URL: https://www.bartscancer.london/in-the-media/2024/05/thomas-powles-named-in-times-list-of-the-100-most-influential-people-in-global-health-this-year/

Professor Thomas Powles

WEBPembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma. N Engl J Med (2019) 380(12):1116-1127. PMID: 30779529 Atezolizumab plus bevacizumab …

Category: Health Go Health

Professor Thomas Powles selected as one of Nature’s top ten …

WEBFor over a decade, leading science journal Nature has published a list – Nature’s 10 – that explores the year's key developments in science and recognises ten …

Category: Health Go Health

Professor Peter Schmid

WEBPembrolizumab for Early Triple-Negative Breast Cancer. N Engl J Med (2020) 382(9):810-821. PMID: 32101663 Pembrolizumab plus chemotherapy versus placebo plus …

Category: Cancer Go Health

Dr Rifca Le Dieu

WEBBiography. I am an Honorary Consultant at Barts Health NHS Trust where I have a lymphoma practice. I trained at St John’s College, Cambridge and Imperial College, …

Category: Health Go Health

NHS Innovation Accelerator

WEBNHS Innovation Accelerator. Dr Ranjit Manchanda from Barts Cancer Institute, Queen Mary University of London, and Consultant Gynaecological Oncologist …

Category: Cancer Go Health

Centre for Experimental Cancer Medicine

WEBThe Centre for Experimental Cancer Medicine (CECM) is part of the Barts ECMC.The team comprises of an academically led Trials Team responsible for the development and …

Category: Cancer, Medicine Go Health

About the Cancer Research UK Barts Centre

WEBThe Cancer Research UK (CRUK) Barts Centre, a partnership between Queen Mary University of London's Barts Cancer Institute and Centre for Prevention, Detection and …

Category: Cancer Go Health

Professor Kamil R. Kranc

WEBThe mRNA m6A reader YTHDF2 suppresses proinflammatory pathways and sustains hematopoietic stem cell function. J Exp Med (2021) 218(3):e20200829. PMID: 33156926 …

Category: Health Go Health

Professor Claude Chelala

WEBMajor Funding. 2021-2023- Data-driven risk and prognosis prediction from EHRs, CAP-AI, £100K 2021-2026- Precision Medicine - Unlocking the longitudinal Electronic Health …

Category: Medicine Go Health

Professor Hemant Kocher

WEBRecent Publications. CD73 controls Myosin II-driven invasion, metastasis, and immunosuppression in amoeboid pancreatic cancer cells Samain R, Maiques O, Monger …

Category: Cancer Go Health

Professor Michelle Lockley

WEBMajor Funding. 2022-2027 - Anticancer Fund, RFA Evolutionary Therapy (2021-2027) “ACTOv: Adaptive ChemoTherapy for Ovarian cancer”, €496,611

Category: Cancer Go Health

Barts Cancer Institute Tissue Banks

WEBThe Barts Cancer Institute hosts four local Tissue Banks: Barts Gynae Tissue Bank, The Haemato-Oncology Study Tissue Bank, The Cancer Tissue Bank and Barts Pancreas …

Category: Cancer Go Health

Professor Daniel M Berney

WEBGroup Leader, Honorary staff. Overview. Research. Other Activities. Major Funding. Biography. Daniel M Berney is a Consultant Pathologist at Barts Health NHS Trust and …

Category: Health Go Health

Professor Ranjit Manchanda

WEBA cost-effectiveness analysis of multigene testing for all patients with breast cancer. JAMA Oncol (2019). PMID: 31580391 Cost-effectiveness of population-based BRCA1, BRCA2, …

Category: Cancer Go Health

Radionuclides for Health UK

WEBMolecular radiotherapy treatment is dependent on a stable supply of radionuclides. The supply of radionuclides into the UK has been impacted by a combination of factors, …

Category: Health Go Health